Current Cancer Drug Targets
Title:Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy)
Volume: 16 Issue: 8
Author(s): Maria Bozko, Monika Podhorecka, Arkadiusz Macheta, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko
Affiliation:
Export Options
About this article
Cite this article as:
Bozko Maria, Podhorecka Monika, Macheta Arkadiusz, Bozko Andrzej, Malek P. Nisar and Bozko Przemyslaw, Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy), Current Cancer Drug Targets 2016; 16 (8) . https://dx.doi.org/10.2174/156800961608160902101746
DOI https://dx.doi.org/10.2174/156800961608160902101746 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Nanoparticles: Properties and Applications in Cancer Immunotherapy
Current Pharmaceutical Design Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells
Mini-Reviews in Medicinal Chemistry Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors
Current Drug Targets The Ligand Nanoparticle Conjugation Approach for Targeted Cancer Therapy
Current Drug Metabolism Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Mini-Reviews in Medicinal Chemistry Dual Function of Nitric Oxide in Carcinogenesis, Reappraisal
Current Drug Metabolism Applications of Magnetic Liposomes in Cancer Therapies
Current Pharmaceutical Design Glycoprotein Targeting and Other Applications of Lectins in Biotechnology
Current Protein & Peptide Science In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib
Current Drug Delivery Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer
Current Molecular Medicine Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets Preface
Current Cancer Therapy Reviews Titanium Oxide Nanoparticles Improve the Chemotherapeutic Action of Erlotinib in Liver Cancer Cells
Current Cancer Therapy Reviews New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases
Current Drug Therapy Lipids as Activators of Innate Immunity in Peptide Vaccine Delivery
Current Medicinal Chemistry Kinase Inhibitors in Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Exploring the Role of Polysaccharides in Drug Delivery)
Current Pharmaceutical Design Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1
Recent Patents on Biomarkers Fc Receptors as Potential Targets for the Treatment of Allergy, Autoimmune Disease and Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders